Since the MAPK signaling pathway is known to be involved in cardiac hypertrophy [27] and inflammation promotion [12], it is not surprising to see that A2-4-2-4 inhibited inflammation and cardiac hypertrophy (based on the COX-2 and tnnt2 qRT-PCR results, respectively). This evidence concerns the gene TNNT2 and cardiac hypertrophy.